Quantitative Detection of Promoter Hypermethylation as a Biomarker of Acute Kidney Injury During Transplantation
- 31 December 2006
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 38 (10), 3420-3426
- https://doi.org/10.1016/j.transproceed.2006.10.149
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung CancerClinical Cancer Research, 2004
- Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid TumorigenesisCancer Research, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Demethylation by 5-aza-2??-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ?? gene in human colon carcinoma cellsAnti-Cancer Drugs, 1998
- Treatment of acute renal failureKidney International, 1998
- DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia (ALL)Leukemia, 1997
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986